Alembic Pharmaceuticals Limited (NSE:APLLTD)

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 26.03B INR in the quarter ending September 30, 2026, with 36.30% growth. This brings the company's total for the last twelve months to 84.77B, up 19.68% year-over-year. In the fiscal year ending March 31, 2026, Alembic Pharmaceuticals had annual revenue of 73.45B with 10.08% growth. That makes Alembic Pharmaceuticals the 8,081st largest company in the world by revenue and 323rd in India.

• Revenue (ttm): 84.77B
• Revenue Growth: +19.68%
• P/S Ratio: 2.42
• Revenue / Employee: 4.92M
• Employees: 17,244
• Market Cap: 205.21B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Outside India 46.00B 62.6%
• India 27.45B 37.4%

Fiscal year ended Mar 31, 2026 See the full Alembic Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	73.45B	6.73B	10.08%
Mar 31, 2025	66.72B	4.43B	7.12%
Mar 31, 2024	62.29B	5.76B	10.19%
Mar 31, 2023	56.53B	3.47B	6.54%
Mar 31, 2022	53.06B	-873.40M	-1.62%

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error